(Q40428841)

20 September 2017

title

Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma (English)

1 reference

20 September 2017

Seong-Il Suh

1 reference

20 September 2017

Tae-Il Jung

1 reference

20 September 2017

Won-Ki Baek

1 reference

20 September 2017

Byeong-Churl Jang

1 reference

20 September 2017

Dae-Kyu Song

1 reference

20 September 2017

Jae-Hoon Bae

1 reference

20 September 2017

Kun-Young Kwon

1 reference

20 September 2017

Ji-Hyun Bae

1 reference

20 September 2017

Soon-Do Cha

1 reference

20 September 2017

Insoo Bae

1 reference

20 September 2017

Chi-Heum Cho

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

365-373

1 reference

20 September 2017

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

The causal relation between human papillomavirus and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Natural history of cervicovaginal papillomavirus infection in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

The molecular genetics of cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Expression and cDNA cloning of porcine peroxisome proliferator-activated receptor gamma (PPARgamma).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

APC-dependent suppression of colon carcinogenesis by PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

p21 is a universal inhibitor of cyclin kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Overexpression of p21WAF1/CIP1 induces cell differentiation and growth inhibition in a human glioma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.019

10.1016/J.YGYNO.2005.01.019

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference